Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhönen, T Kuitunen, P Nyandoto & M Kouri.
Naureen StarlingDavid CunninghamPublished in: British journal of cancer (2023)
We discuss Pyrhönen's paper as a catalyst for defining systemic therapy approaches in gastric cancer and how the field has evolved in the last two decades in sequential, targeted and more recently immune-directed therapies and how it may develop to transform survival in this cancer of high unmet need.
Keyphrases
- healthcare
- palliative care
- clinical trial
- quality improvement
- papillary thyroid
- open label
- affordable care act
- high dose
- squamous cell carcinoma
- cancer therapy
- locally advanced
- ionic liquid
- highly efficient
- young adults
- bone marrow
- low dose
- stem cells
- gold nanoparticles
- health insurance
- metal organic framework
- drug induced
- replacement therapy